✨
AI Summary
- Cereno Scientific repurposes an epilepsy drug for rare cardiopulmonary diseases.
- Phase IIa results show improved heart function and reduced mortality.
- FDA fast track designation and strategy for pivotal trials.
Guests on This Episode
SS
Sten Sorensen
1 podcast appearance